Ryan & Maniskas, LLP Announces Investigation of Arch Chemicals, Inc.
12 Julho 2011 - 11:48AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/arj) is
investigating potential claims against the board of directors of
Arch Chemicals, Inc. ("Arch Chemicals" or the "Company") (NYSE:
ARJ) concerning possible breaches of fiduciary duty and other
violations of law related to the Company’s efforts to sell Arch
Chemicals to Lonza Ltd. in a transaction valued at approximately
$1.2 billion.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by Company’s board of directors; in particular, whether
the Company undertook a fair process to obtain fair consideration
for all shareholders of Arch Chemicals. For more information
regarding our investigation, please contact Ryan & Maniskas,
LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or
by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/arj.
Under the terms of the definitive agreement, Arch Chemicals
shareholders will receive $47.20 in cash for each share of Arch
Chemicals common stock that they own.
If you own shares of Arch Chemicals and would like to learn more
about these claims or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/arj. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Arch Chemicals (NYSE:ARJ)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Arch Chemicals (NYSE:ARJ)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Arch Chemicals da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Ryan & Maniskas, LLP